Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lianlin Zeng"'
Autor:
Wei Jiang, Haixu Chen, Yu Lin, Kang Cheng, Daqian Zhou, Rui Chen, Chao Song, Lianlin Zeng, Hong Yu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 167, Iss , Pp 115552- (2023)
Knee osteoarthritis (KOA) is a common chronic disease in orthopedics, which brings great pain to patients' life and spirit. Therefore, it is necessary to elucidate the pathogenesis of KOA. The pathophysiology of KOA has been linked to numerous factor
Externí odkaz:
https://doaj.org/article/d268a3bc77494e48b1474deab8dce558
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/8539c97c489147fcaa167ad71d456b5e
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-22 (2021)
Abstract Background Tubulointerstitial fibrosis (TIF) is one of the main pathological features of various progressive renal damages and chronic kidney diseases. Mesenchymal stromal cells (MSCs) have been verified with significant improvement in the t
Externí odkaz:
https://doaj.org/article/d7fcf88d078f4fb0a5bab0b350e33f2f
Publikováno v:
Medicine; 9/13/2024, Vol. 103 Issue 37, p1-9, 9p
Publikováno v:
Medicine. 101(51)
To explore the mechanism of compound Hongginshen decoction in improving pulmonary fibrosis based on network pharmacology.The active components and targets of ginseng and Salvia miltiorrhiza were screened from the Traditional Chinese Medicine Systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01d57bcec64d4a16b86a6c3efa21acb
https://pubmed.ncbi.nlm.nih.gov/36595795
https://pubmed.ncbi.nlm.nih.gov/36595795
Autor:
Lianlin Zeng, Xia Liu, Tao Li, Wei Zhang, Wenying Li, Peichen Wu, Yangping Lv, Zhengli Zhou, Chunling Wu, Bo Chen
Background TGF-β1 has been recognized as the core driver of renal fibrosis and involved in the pathophysiological process from chronic kidney disease (CKD) to end-stage renal disease (ESRD). RepSox is an effective and selective inhibitor of TGFβR-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c1186fa0fc132cc4893539fec6dbc4b
https://doi.org/10.21203/rs.3.rs-1820360/v1
https://doi.org/10.21203/rs.3.rs-1820360/v1
Publikováno v:
International journal of stem cells.
Epithelial-Mesenchymal transition (EMT) is one of the origins of myofibroblasts in renal interstitial fibrosis. Mesenchymal stem cells (MSCs) alleviating EMT has been proved, but the concrete mechanism is unclear. To explore the mechanism, serum-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b54f7877882e0717719f9e805ed1b21
https://pubmed.ncbi.nlm.nih.gov/35483714
https://pubmed.ncbi.nlm.nih.gov/35483714
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-22 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-22 (2021)
Background Tubulointerstitial fibrosis (TIF) is one of the main pathological features of various progressive renal damages and chronic kidney diseases. Mesenchymal stromal cells (MSCs) have been verified with significant improvement in the therapy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40db5ca91f7ba9a183006dde16fbb06a
https://doi.org/10.1186/s13287-021-02429-z
https://doi.org/10.1186/s13287-021-02429-z
Background: Tubulointerstitial fibrosis (TIF) is one of the main pathological features of various progressive renal damages and chronic kidney diseases. Mesenchymal stromal cells (MSCs) have been verified with significant improvement in the therapy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be1504f32567da3f0c3a44bdc765463f
https://doi.org/10.21203/rs.3.rs-100450/v1
https://doi.org/10.21203/rs.3.rs-100450/v1